| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $200K | — | — |
| R&D Expense | $33K | — | +14.7% |
| SG&A Expense | $752K | — | +22.2% |
| Operating Income | -$1.6M | — | -126.9% |
| Pre-tax Income | -$1.7M | — | -79.0% |
| Net Income | -$1.6M | — | -85.3% |
| EPS (Basic) | -$0.06 | — | +0.0% |
| EPS (Diluted) | -$0.06 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $140K | -79.4% | -7.8% |
| Short-term Investments | $62K | -3.4% | -4.4% |
| Current Assets | $649K | -74.1% | -55.8% |
| Total Assets | $19.7M | -6.3% | +32.6% |
| Current Liabilities | $5.4M | -12.5% | -19.9% |
| Total Liabilities | $6.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$894K | — | -65.7% |
| Investing Cash Flow | $47K | — | — |
| Financing Cash Flow | -$342K | — | -179.8% |
| -0.2% |
| Stockholders' Equity | $10.8M | -3.1% | +99.3% |